Lab & Pathology Information Systems · Healthcare & Life Sciences
Should you build or buy Digital Pathology Image Management?
Digital pathology image management software stores, serves, and manages whole-slide images (WSI) generated by pathology scanners — handling the storage infrastructure, diagnostic-quality tile rendering, DICOM-pathology compliance, and AI overlay pipelines that pathologists use for remote review, telepathology, and computational diagnostics.
The build-vs-buy decision for Digital Pathology Image Management turns on how central your institution's AI pathology program is to competitive positioning versus how much of the value comes from vendor-built scanner integrations and DICOM compliance infrastructure that few teams can replicate; the specifics — whether you're building an AI runway or running clinical telepathology — decide it.
Build it, buy it, or bridge?
When building makes sense
Building digital pathology image management infrastructure at the core level — the WSI storage, tile rendering, and DICOM compliance stack — is not a realistic option for most institutions given the technical depth required. What is buildable, and genuinely strategic, is the layer above: the AI model integration pipeline, the case routing logic that determines which slides flow to which algorithms, the workflow through which pathologists interact with computational outputs, and the training data curation tooling that feeds model development. For an academic cancer center where computational pathology is a research priority and AI diagnostics are under active development, owning that integration and data architecture layer is a legitimate competitive decision. The key test is whether the institution can specifically articulate how controlling its image data schema and AI deployment architecture changes its research or clinical outcomes — if that answer is concrete, the investment has a foundation. If it's theoretical, the cost of building on top of a $40-100GB-per-slide infrastructure problem usually isn't justified.
When buying makes sense
Buying digital pathology image management is the practical choice when the primary use case is clinical telepathology, remote consultation, or digital primary diagnosis rather than AI research. The core infrastructure problem — serving 40 to 100 gigabyte whole-slide images at diagnostic quality with sub-millisecond tile rendering — requires specialized storage architecture and viewer performance that vendors like Proscia (Concentriq) and Sectra Digital Pathology have engineered through years of direct work with scanner manufacturers. Leica, Aperio, and other scanners use proprietary image formats and APIs that vendor platforms integrate through established partnerships. DICOM-pathology compliance adds another layer that requires ongoing maintenance as standards evolve. For a community pathology lab deploying digital workflows for workflow efficiency or remote coverage, or a health system adding telepathology to extend specialist access, vendor selection and implementation is almost always the right shape — the infrastructure complexity is too high and the differentiation opportunity too low to justify building.
The desk read
Whole-slide imaging generates 40 to 100 gigabytes per slide. Serving those images at diagnostic quality requires specialized tile rendering infrastructure, DICOM-pathology compliance, and instrument integration with scanners from Leica, Aperio, and others that use proprietary APIs. Vendors like Proscia and Sectra Digital Pathology have built those integrations over years of direct hardware partnerships, and the combined stack isn't independently replicable for most institutions.
The strategic picture differs sharply by institution. For an academic cancer center with an active computational pathology program, the image management platform determines what AI models can be deployed, how training data is curated, and how pathologist workflows interact with algorithmic overlays. That makes vendor selection a genuine strategic decision with real infrastructure consequences, well beyond a routine procurement. For a community lab using digital pathology for telepathology only, buying Roche navify or a Fujifilm Synapse stack earns its keep on the integration and compliance work alone.
Frequently asked
What is Digital Pathology Image Management?
Digital pathology image management software stores, serves, and manages whole-slide images (WSI) generated by pathology scanners — handling the storage infrastructure, diagnostic-quality tile rendering, DICOM-pathology compliance, and AI overlay pipelines that pathologists use for remote review, telepathology, and computational diagnostics.
When does building Digital Pathology Image Management make sense?
Building the AI integration and case routing layer above a vendor platform is defensible for academic cancer centers with active computational pathology programs. Building the core WSI storage and compliance infrastructure is not realistic for most institutions given the scanner integration complexity and DICOM requirements involved.
When does buying Digital Pathology Image Management make sense?
Buying is the right call for health systems deploying telepathology or digital primary diagnosis, where vendor scanner certifications, DICOM compliance, and established tile-rendering infrastructure eliminate years of engineering work that doesn't create competitive advantage.
What are the main Digital Pathology Image Management vendors?
Representative vendors include Proscia (Concentriq), Sectra Digital Pathology, Roche navify Digital Pathology, Paige. B4 Pro scores the full set.
How large are whole-slide pathology images and why does that matter for the build-vs-buy question?
A single whole-slide image runs 40 to 100 gigabytes. Serving those at diagnostic quality requires specialized tile-rendering infrastructure and storage architecture that most development teams haven't built before. This infrastructure complexity is a meaningful factor in why vendor platforms carry substantial switching costs once deployed.